U.S., Nov. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07950579) titled 'OvariAn Secretome and Integrated HealthSpan' on Oct. 22.

Brief Summary: The OASIS study aims to identify and characterize circulating molecular signatures associated with ovarian aging, and to determine how these signatures relate to multidomain healthspan during the menopausal transition. The study consists of three parts. Part 1 is a retrospective analysis of existing clinical data and stored biospecimens from approximately 500 women aged 50-85 years. Part 2 is a prospective cohort of 300 women aged 40-50 years who will undergo comprehensive clinical, gynecological, and molecular assessments over 24 months, followed by individuali...